Latest CLLS reports update at 2024-05-11: 2023 ∙ 2022 ∙ 2021

Cellectis S.A. CLLS

$ 3.24 4.52%

Cellectis S.A. Balance Sheet 2011-2024 | CLLS

Annual Balance Sheet Cellectis S.A.

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-	-206 M	-293 M	-450 M	-256 M	-252 M	-342 M	-132 M	-4.82 M	-23.2 M	14.1 M
Long Term Debt	-	-	-	28.8 M	46.5 M	1.02 M	13 K	29.4 K	2.19 K	3.38 M	4.23 M	4.37 M	67.5 M
Long Term Debt Current	8.5 M	7.87 M	8.33 M	6.7 M	1.07 M	333 K	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	109 M	49.4 M	3.7 M	3.44 M	589 K	550 K	3.92 M	5.26 M	5.06 M	67.9 M
Total Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	-	-	-	161 M	112 M	50.6 M	47 M	56.6 M	84.7 M	95 M	37.5 M	33.4 M	94.9 M
Deferred Revenue	-	-	-	452 K	20 M	20.8 M	26.1 M	38.8 M	59.9 M	72.3 M	7.75 M	-	-
Retained Earnings	-	-	-	-506 M	-406 M	-327 M	-252 M	-166 M	-150 M	-	-	-	-67.2 M
Total Assets	334 M	261 M	382 M	469 M	467 M	501 M	333 M	331 M	373 M	167 M	44.1 M	115 M	132 M
Cash and Cash Equivalents	137 M	89.8 M	186 M	241 M	341 M	452 M	256 M	255 M	342 M	-	-	-	-
Book Value	-	-	382 M	309 M	355 M	450 M	286 M	274 M	288 M	72.4 M	6.65 M	81.7 M	37 M
Total Shareholders Equity	-	-	-	309 M	355 M	450 M	284 M	273 M	287 M	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet Cellectis S.A.

	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	-	-	-	-	71.5 M	-	75.8 M	-	75.8 M	-	64.9 M	-	46.5 M	-	-	-	1.02 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	96.3 M	-	104 M	-	109 M	-	74.6 M	-	49.4 M	-	-	-	3.7 M	-	-	-	3.44 M	-	-	-	590 K	-	-	-	548 K	-	-	-	3.91 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-	-	-	-	-	-	-586 M	-	-506 M	-	-509 M	-	-406 M	-	-	-	-327 M	-	-	-	-254 M	-	-	-	-210 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	-	-	-	-	382 M	-	458 M	-	469 M	-	473 M	-	467 M	-	-	-	501 M	-	-	-	333 M	-	-	-	331 M	-	-	-	371 M	-	-	-	167 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	-	-	-	-	186 M	-	248 M	-	241 M	-	261 M	-	341 M	-	397 M	-	452 M	-	-	-	256 M	-	-	-	255 M	-	-	-	342 M	-	-	-	136 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	-	-	-	-	382 M	-	458 M	-	469 M	-	473 M	-	467 M	-	-	-	501 M	-	-	-	333 M	-	-	-	331 M	-	-	-	371 M	-	-	-	167 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	-	-	-	-	236 M	-	302 M	-	309 M	-	345 M	-	355 M	-	405 M	-	450 M	-	-	-	284 M	-	-	-	273 M	-	-	-	285 M	-	-	-	72.3 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency